These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preservation of ischemic myocardium by pinane thromboxane A2. Schrör K, Smith EF, Bickerton M, Smith JB, Nicolaou KC, Magolda R, Lefer AM. Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037 [Abstract] [Full Text] [Related]
4. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium. Lefer AM, Mentley R, Sun JZ. Circ Res; 1988 Sep; 63(3):621-7. PubMed ID: 3136950 [Abstract] [Full Text] [Related]
8. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. Tanabe M, Terashita Z, Nishikawa K, Hirata M. J Cardiovasc Pharmacol; 1984 Jun; 6(3):442-8. PubMed ID: 6202970 [Abstract] [Full Text] [Related]
9. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats. Brezinski ME, Yanagisawa A, Darius H, Lefer AM. Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159 [Abstract] [Full Text] [Related]
10. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction. Tada M, Hoshida S, Kuzuya T, Inoue M, Minamino T, Abe H. Int J Cardiol; 1985 Jul; 8(3):301-12. PubMed ID: 4040500 [Abstract] [Full Text] [Related]
15. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin. Bertele V, De Gaetano G. Eur J Pharmacol; 1982 Dec 03; 85(3-4):331-3. PubMed ID: 6295787 [Abstract] [Full Text] [Related]
16. Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen. Smith EF, Lefer AM. Am Heart J; 1981 Apr 03; 101(4):394-402. PubMed ID: 7211667 [Abstract] [Full Text] [Related]
17. Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. Leprán I, Lefer AM. Basic Res Cardiol; 1985 Apr 03; 80(2):135-41. PubMed ID: 4039929 [Abstract] [Full Text] [Related]
18. Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat. Lefer AM, Polansky EW, Bianchi CP, Narayan S. Basic Res Cardiol; 1979 Apr 03; 74(5):555-67. PubMed ID: 526260 [Abstract] [Full Text] [Related]
19. Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor. Burke SE, Lefer AM, Smith GM, Smith JB. Br J Clin Pharmacol; 1983 Apr 03; 15 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6681711 [Abstract] [Full Text] [Related]
20. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia. Schrör K, Ohlendorf R, Darius H. J Pharmacol Exp Ther; 1981 Oct 03; 219(1):243-9. PubMed ID: 6169823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]